Global and United States Non-Hematological Cancer Treatment Market Report & Forecast 2023-2028

Report ID: 1860796 | Published Date: Sep 2024 | No. of Page: 92 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Non-Hematological Cancer Treatment Revenue in Non-Hematological Cancer Treatment Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Non-Hematological Cancer Treatment Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Non-Hematological Cancer Treatment Market Size for the Year 2017-2028
        1.2.2 Global Non-Hematological Cancer Treatment Market Size for the Year 2017-2028
    1.3 Non-Hematological Cancer Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Non-Hematological Cancer Treatment in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Non-Hematological Cancer Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Non-Hematological Cancer Treatment Market Dynamics
        1.4.1 Non-Hematological Cancer Treatment Industry Trends
        1.4.2 Non-Hematological Cancer Treatment Market Drivers
        1.4.3 Non-Hematological Cancer Treatment Market Challenges
        1.4.4 Non-Hematological Cancer Treatment Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Non-Hematological Cancer Treatment by Type
    2.1 Non-Hematological Cancer Treatment Market Segment by Type
        2.1.1 Chemotherapy
        2.1.2 Surgery
        2.1.3 Radiation Therapy
        2.1.4 Others
    2.2 Global Non-Hematological Cancer Treatment Market Size by Type (2017, 2022 & 2028)
    2.3 Global Non-Hematological Cancer Treatment Market Size by Type (2017-2028)
    2.4 United States Non-Hematological Cancer Treatment Market Size by Type (2017, 2022 & 2028)
    2.5 United States Non-Hematological Cancer Treatment Market Size by Type (2017-2028)
3 Non-Hematological Cancer Treatment by Application
    3.1 Non-Hematological Cancer Treatment Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Oncology Treatment Centre
        3.1.3 Ambulatory Surgery Centers
        3.1.4 Others
    3.2 Global Non-Hematological Cancer Treatment Market Size by Application (2017, 2022 & 2028)
    3.3 Global Non-Hematological Cancer Treatment Market Size by Application (2017-2028)
    3.4 United States Non-Hematological Cancer Treatment Market Size by Application (2017, 2022 & 2028)
    3.5 United States Non-Hematological Cancer Treatment Market Size by Application (2017-2028)
4 Global Non-Hematological Cancer Treatment Competitor Landscape by Company
    4.1 Global Non-Hematological Cancer Treatment Market Size by Company
        4.1.1 Top Global Non-Hematological Cancer Treatment Companies Ranked by Revenue (2021)
        4.1.2 Global Non-Hematological Cancer Treatment Revenue by Player (2017-2022)
    4.2 Global Non-Hematological Cancer Treatment Concentration Ratio (CR)
        4.2.1 Non-Hematological Cancer Treatment Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Non-Hematological Cancer Treatment in 2021
        4.2.3 Global Non-Hematological Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Non-Hematological Cancer Treatment Headquarters, Revenue in Non-Hematological Cancer Treatment Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Non-Hematological Cancer Treatment Headquarters and Area Served
        4.3.2 Global Non-Hematological Cancer Treatment Companies Revenue in Non-Hematological Cancer Treatment Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Non-Hematological Cancer Treatment Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Non-Hematological Cancer Treatment Market Size by Company
        4.5.1 Top Non-Hematological Cancer Treatment Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Non-Hematological Cancer Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Non-Hematological Cancer Treatment Market Size by Region
    5.1 Global Non-Hematological Cancer Treatment Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Non-Hematological Cancer Treatment Market Size by Region (2017-2028)
        5.2.1 Global Non-Hematological Cancer Treatment Market Size by Region: 2017-2022
        5.2.2 Global Non-Hematological Cancer Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Non-Hematological Cancer Treatment Market Size YoY Growth 2017-2028
        6.1.2 North America Non-Hematological Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Non-Hematological Cancer Treatment Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Non-Hematological Cancer Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Non-Hematological Cancer Treatment Market Size YoY Growth 2017-2028
        6.3.2 Europe Non-Hematological Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Non-Hematological Cancer Treatment Market Size YoY Growth 2017-2028
        6.4.2 Latin America Non-Hematological Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Non-Hematological Cancer Treatment Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Non-Hematological Cancer Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Novartis
        7.1.1 Novartis Company Details
        7.1.2 Novartis Business Overview
        7.1.3 Novartis Non-Hematological Cancer Treatment Introduction
        7.1.4 Novartis Revenue in Non-Hematological Cancer Treatment Business (2017-2022)
        7.1.5 Novartis Recent Development
    7.2 Pfizer
        7.2.1 Pfizer Company Details
        7.2.2 Pfizer Business Overview
        7.2.3 Pfizer Non-Hematological Cancer Treatment Introduction
        7.2.4 Pfizer Revenue in Non-Hematological Cancer Treatment Business (2017-2022)
        7.2.5 Pfizer Recent Development
    7.3 Bristol-Myers Squibb
        7.3.1 Bristol-Myers Squibb Company Details
        7.3.2 Bristol-Myers Squibb Business Overview
        7.3.3 Bristol-Myers Squibb Non-Hematological Cancer Treatment Introduction
        7.3.4 Bristol-Myers Squibb Revenue in Non-Hematological Cancer Treatment Business (2017-2022)
        7.3.5 Bristol-Myers Squibb Recent Development
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Company Details
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson Non-Hematological Cancer Treatment Introduction
        7.4.4 Johnson & Johnson Revenue in Non-Hematological Cancer Treatment Business (2017-2022)
        7.4.5 Johnson & Johnson Recent Development
    7.5 Roche
        7.5.1 Roche Company Details
        7.5.2 Roche Business Overview
        7.5.3 Roche Non-Hematological Cancer Treatment Introduction
        7.5.4 Roche Revenue in Non-Hematological Cancer Treatment Business (2017-2022)
        7.5.5 Roche Recent Development
    7.6 Amgen
        7.6.1 Amgen Company Details
        7.6.2 Amgen Business Overview
        7.6.3 Amgen Non-Hematological Cancer Treatment Introduction
        7.6.4 Amgen Revenue in Non-Hematological Cancer Treatment Business (2017-2022)
        7.6.5 Amgen Recent Development
    7.7 Astellas Pharma
        7.7.1 Astellas Pharma Company Details
        7.7.2 Astellas Pharma Business Overview
        7.7.3 Astellas Pharma Non-Hematological Cancer Treatment Introduction
        7.7.4 Astellas Pharma Revenue in Non-Hematological Cancer Treatment Business (2017-2022)
        7.7.5 Astellas Pharma Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Non-Hematological Cancer Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Non-Hematological Cancer Treatment Market Trends
    Table 3. Non-Hematological Cancer Treatment Market Drivers
    Table 4. Non-Hematological Cancer Treatment Market Challenges
    Table 5. Non-Hematological Cancer Treatment Market Restraints
    Table 6. Global Non-Hematological Cancer Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Non-Hematological Cancer Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Non-Hematological Cancer Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Non-Hematological Cancer Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Non-Hematological Cancer Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Non-Hematological Cancer Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Non-Hematological Cancer Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Non-Hematological Cancer Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Non-Hematological Cancer Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Hematological Cancer Treatment as of 2021)
    Table 15. Top Players of Non-Hematological Cancer Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Non-Hematological Cancer Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Non-Hematological Cancer Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Non-Hematological Cancer Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Non-Hematological Cancer Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Non-Hematological Cancer Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Non-Hematological Cancer Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Non-Hematological Cancer Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Non-Hematological Cancer Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Non-Hematological Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Non-Hematological Cancer Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Non-Hematological Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Non-Hematological Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Non-Hematological Cancer Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Novartis Company Details
    Table 31. Novartis Business Overview
    Table 32. Novartis Non-Hematological Cancer Treatment Product
    Table 33. Novartis Revenue in Non-Hematological Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 34. Novartis Recent Development
    Table 35. Pfizer Company Details
    Table 36. Pfizer Business Overview
    Table 37. Pfizer Non-Hematological Cancer Treatment Product
    Table 38. Pfizer Revenue in Non-Hematological Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 39. Pfizer Recent Development
    Table 40. Bristol-Myers Squibb Company Details
    Table 41. Bristol-Myers Squibb Business Overview
    Table 42. Bristol-Myers Squibb Non-Hematological Cancer Treatment Product
    Table 43. Bristol-Myers Squibb Revenue in Non-Hematological Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 44. Bristol-Myers Squibb Recent Development
    Table 45. Johnson & Johnson Company Details
    Table 46. Johnson & Johnson Business Overview
    Table 47. Johnson & Johnson Non-Hematological Cancer Treatment Product
    Table 48. Johnson & Johnson Revenue in Non-Hematological Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 49. Johnson & Johnson Recent Development
    Table 50. Roche Company Details
    Table 51. Roche Business Overview
    Table 52. Roche Non-Hematological Cancer Treatment Product
    Table 53. Roche Revenue in Non-Hematological Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 54. Roche Recent Development
    Table 55. Amgen Company Details
    Table 56. Amgen Business Overview
    Table 57. Amgen Non-Hematological Cancer Treatment Product
    Table 58. Amgen Revenue in Non-Hematological Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 59. Amgen Recent Development
    Table 60. Astellas Pharma Company Details
    Table 61. Astellas Pharma Business Overview
    Table 62. Astellas Pharma Non-Hematological Cancer Treatment Product
    Table 63. Astellas Pharma Revenue in Non-Hematological Cancer Treatment Business (2017-2022) & (US$ Million)
    Table 64. Astellas Pharma Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Non-Hematological Cancer Treatment Product Picture
    Figure 2. Global Non-Hematological Cancer Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Non-Hematological Cancer Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Non-Hematological Cancer Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Non-Hematological Cancer Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Non-Hematological Cancer Treatment Market Share in Global 2017-2028
    Figure 7. Non-Hematological Cancer Treatment Report Years Considered
    Figure 8. Product Picture of Chemotherapy
    Figure 9. Product Picture of Surgery
    Figure 10. Product Picture of Radiation Therapy
    Figure 11. Product Picture of Others
    Figure 12. Global Non-Hematological Cancer Treatment Market Share by Type in 2022 & 2028
    Figure 13. Global Non-Hematological Cancer Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Non-Hematological Cancer Treatment Market Share by Type (2017-2028)
    Figure 15. United States Non-Hematological Cancer Treatment Market Share by Type in 2022 & 2028
    Figure 16. United States Non-Hematological Cancer Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Non-Hematological Cancer Treatment Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Oncology Treatment Centre
    Figure 20. Product Picture of Ambulatory Surgery Centers
    Figure 21. Product Picture of Others
    Figure 22. Global Non-Hematological Cancer Treatment Market Share by Application in 2022 & 2028
    Figure 23. Global Non-Hematological Cancer Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Non-Hematological Cancer Treatment Market Share by Application (2017-2028)
    Figure 25. United States Non-Hematological Cancer Treatment Market Share by Application in 2022 & 2028
    Figure 26. United States Non-Hematological Cancer Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Non-Hematological Cancer Treatment Market Share by Application (2017-2028)
    Figure 28. North America Non-Hematological Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Non-Hematological Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Non-Hematological Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Non-Hematological Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Non-Hematological Cancer Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. UAE Non-Hematological Cancer Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Novartis Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2017-2022)
    Figure 57. Pfizer Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2017-2022)
    Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2017-2022)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2017-2022)
    Figure 60. Roche Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2017-2022)
    Figure 61. Amgen Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2017-2022)
    Figure 62. Astellas Pharma Revenue Growth Rate in Non-Hematological Cancer Treatment Business (2017-2022)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis
Pfizer
Bristol-Myers Squibb
Johnson & Johnson
Roche
Amgen
Astellas Pharma
Frequently Asked Questions
Non-Hematological Cancer Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Non-Hematological Cancer Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Non-Hematological Cancer Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports